by Maria Zannes | Oct 16, 2024 | Articles, News
As published in Mergermarket By Deborah Balshem and Jeff Sheban Summary • Medicare reimbursement providing tailwinds • Expansion into government market imminent • Analyst sees labs chains among potential buyers bioAffinity Technologies [NASDAQ:BIAF], a healthcare...
by Maria Zannes | Oct 16, 2024 | Press Releases
bioAffinity VP served on expert panel that published new guidance SAN ANTONIO, TX (Oct. 16, 2024) – bioAffinity Technologies’ (Nasdaq: BIAF) Vice President of Diagnostics, Jennifer Rebeles, Ph.D., was part of a panel of worldwide experts that published the...
by Maria Zannes | Oct 13, 2024 | Articles, News
With a San Antonio biotech firm’s test, your phlegm could help save you from cancer. As published by the San Antonio Express-News By Brandon Lingle, Staff Writer The screening method developed by bio Affinity Technologies Inc. uses Al-aided computer analysis...
by Maria Zannes | Oct 11, 2024 | Articles, News
The Alamo City company has gained new commercial access that could greatly expand its reach and its revenue. As published in the San Antonio Business Journal By W. Scott Bailey – Senior Reporter, San Antonio Business Journal BioAffinity Technologies Inc. has reached a...
by Maria Zannes | Oct 10, 2024 | Press Releases
Edwards rejoins the Company after serving as interim CFO SAN ANTONIO, TX (Oct. 10, 2024) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today announced...
